Literature DB >> 20660867

Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins.

T D Graves1, S Rajakulendran, S M Zuberi, H R Morris, S Schorge, M G Hanna, D M Kullmann.   

Abstract

OBJECTIVE: Episodic ataxia type 1 (EA1) is a monogenic channelopathy caused by mutations of the potassium channel gene KCNA1. Affected individuals carrying the same mutation can exhibit considerable variability in the severity of ataxia, neuromyotonia, and other associated features. We investigated the phenotypic heterogeneity of EA1 in 2 sets of identical twins to determine the contribution of environmental factors to disease severity. One of the mutations was also found in a distantly related family, providing evidence of the influence of genetic background on the EA1 phenotype.
METHODS: We evaluated 3 families with an EA1 phenotype, 2 of which included monozygotic twins. We sequenced the KCNA1 gene and studied the biophysical consequences of the mutations in HEK cells.
RESULTS: We identified a new KCNA1 mutation in each pair of twins. Both pairs reported striking differences in the clinical severity of symptoms. The F414S mutation identified in one set of twins also occurred in a distantly related family in which seizures complicated the EA1 phenotype. The other twins had an R307C mutation, the first EA1 mutation to affect an arginine residue in the voltage-sensor domain. Both mutants when expressed exerted a dominant-negative effect on wild-type channels.
CONCLUSION: These results broaden the range of KCNA1 mutations and reveal an unexpectedly large contribution of nongenetic factors to phenotypic variability in EA1. The occurrence of epilepsy in 1 of 2 families with the F414S mutation suggests an interplay of KCNA1 with other genetic factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660867      PMCID: PMC2918890          DOI: 10.1212/WNL.0b013e3181ea9ee3

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy.

Authors:  T Sugawara; E Mazaki-Miyazaki; K Fukushima; J Shimomura; T Fujiwara; S Hamano; Y Inoue; K Yamakawa
Journal:  Neurology       Date:  2002-04-09       Impact factor: 9.910

2.  Spinocerebellar ataxia in monozygotic twins.

Authors:  John H Anderson; Peka S Christova; Ting-dong Xie; Kelly S Schott; Kenneth Ward; Christopher M Gomez
Journal:  Arch Neurol       Date:  2002-12

3.  Identical twins with long QT syndrome associated with a missense mutation in the S4 region of the HERG.

Authors:  K Hayashi; M Shimizu; H Ino; K Okeie; M Yamaguchi; T Yasuda; N Fujino; H Fujii; S Fujita; H Mabuchi
Journal:  Jpn Heart J       Date:  2000-05

4.  Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release.

Authors:  Joost H Heeroma; Christian Henneberger; Sanjeev Rajakulendran; Michael G Hanna; Stephanie Schorge; Dimitri M Kullmann
Journal:  Dis Model Mech       Date:  2009-09-24       Impact factor: 5.758

5.  Episodic ataxia/myokymia syndrome is associated with point mutations in the human potassium channel gene, KCNA1.

Authors:  D L Browne; S T Gancher; J G Nutt; E R Brunt; E A Smith; P Kramer; M Litt
Journal:  Nat Genet       Date:  1994-10       Impact factor: 38.330

6.  A novel KCNA1 mutation identified in an Italian family affected by episodic ataxia type 1.

Authors:  P Imbrici; F Gualandi; M C D'Adamo; M Taddei Masieri; P Cudia; D De Grandis; R Mannucci; I Nicoletti; S J Tucker; A Ferlini; M Pessia
Journal:  Neuroscience       Date:  2008-09-24       Impact factor: 3.590

Review 7.  Episodic ataxia type 1: a neuronal potassium channelopathy.

Authors:  Sanjeev Rajakulendran; Stephanie Schorge; Dimitri M Kullmann; Michael G Hanna
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

  7 in total
  19 in total

1.  Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations.

Authors:  Catherine A Brownstein; Alan H Beggs; Lance Rodan; Jiahai Shi; Meghan C Towne; Renee Pelletier; Siqi Cao; Paul A Rosenberg; David K Urion; Jonathan Picker; Wen-Hann Tan; Pankaj B Agrawal
Journal:  Neurogenetics       Date:  2015-09-22       Impact factor: 2.660

Review 2.  The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.

Authors:  Stefan Kipfer; Michael Strupp
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

Review 3.  Paroxysmal Movement Disorders: Recent Advances.

Authors:  Zheyu Xu; Che-Kang Lim; Louis C S Tan; Eng-King Tan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-11       Impact factor: 5.081

4.  Scn2a deletion improves survival and brain-heart dynamics in the Kcna1-null mouse model of sudden unexpected death in epilepsy (SUDEP).

Authors:  Vikas Mishra; Bharat K Karumuri; Nicole M Gautier; Rui Liu; Timothy N Hutson; Stephanie L Vanhoof-Villalba; Ioannis Vlachos; Leonidas Iasemidis; Edward Glasscock
Journal:  Hum Mol Genet       Date:  2017-06-01       Impact factor: 6.150

5.  Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1.

Authors:  Susan E Tomlinson; S Veronica Tan; Dimitri M Kullmann; Robert C Griggs; David Burke; Michael G Hanna; Hugh Bostock
Journal:  Brain       Date:  2010-11-23       Impact factor: 13.501

6.  Novel phenotype associated with a mutation in the KCNA1(Kv1.1) gene.

Authors:  Maria C D'Adamo; Constanze Gallenmüller; Ilenio Servettini; Elisabeth Hartl; Stephen J Tucker; Larissa Arning; Saskia Biskup; Alessandro Grottesi; Luca Guglielmi; Paola Imbrici; Pia Bernasconi; Giuseppe Di Giovanni; Fabio Franciolini; Luigi Catacuzzeno; Mauro Pessia; Thomas Klopstock
Journal:  Front Physiol       Date:  2015-01-15       Impact factor: 4.566

7.  Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation.

Authors:  Tracey D Graves; Yoon-Hee Cha; Angelika F Hahn; Richard Barohn; Mohammed K Salajegheh; Robert C Griggs; Brian N Bundy; Joanna C Jen; Robert W Baloh; Michael G Hanna
Journal:  Brain       Date:  2014-02-26       Impact factor: 13.501

Review 8.  Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels.

Authors:  Francesco Miceli; Maria Virginia Soldovieri; Paolo Ambrosino; Michela De Maria; Laura Manocchio; Alessandro Medoro; Maurizio Taglialatela
Journal:  Front Cell Neurosci       Date:  2015-07-15       Impact factor: 5.505

Review 9.  New insights into the pathogenesis and therapeutics of episodic ataxia type 1.

Authors:  Maria Cristina D'Adamo; Sonia Hasan; Luca Guglielmi; Ilenio Servettini; Marta Cenciarini; Luigi Catacuzzeno; Fabio Franciolini
Journal:  Front Cell Neurosci       Date:  2015-08-19       Impact factor: 5.505

10.  Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1.

Authors:  Susan Elizabeth Tomlinson; Sanjeev Rajakulendran; Stella Veronica Tan; Tracey Dawn Graves; Doris-Eva Bamiou; Robyn W Labrum; David Burke; Carolyn M Sue; Paola Giunti; Stephanie Schorge; Dimitri M Kullmann; Michael G Hanna
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-24       Impact factor: 13.654

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.